AMD: Targeted Suprachoroidal Access for Safer, More Precise Chorio- Retinal Drug Administration
Time: 10:15 am
day: Day2
Details:
- Comparing suprachoroidal delivery to conventional intravitreal injections: advantages in localizing therapy closer to disease sites with potentially improved safety profiles
- Exploring how suprachoroidal administration may limit anterior segment exposure and systemic circulation, reducing off-target effects
- Evaluating the potential to combine suprachoroidal delivery with gene therapy, small molecules, and sustained-release formulations to enhance efficacy
